Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management

Triple negative breast cancer (TNBC) is a subtype of breast cancer which does not express or expresses a minimum amount of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2) protein. TNBCs include a heterogenic group of cancers that are aggressiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorenšek, Rok, Kresnik, Martin, Takač, Iztok, Rojko, Tomaž, Sobočan, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627091/
https://www.ncbi.nlm.nih.gov/pubmed/37936879
http://dx.doi.org/10.2147/BCTT.S399157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627091/
https://www.ncbi.nlm.nih.gov/pubmed/37936879
http://dx.doi.org/10.2147/BCTT.S399157

Ejemplares similares